Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Eun Ho | - |
dc.contributor.author | Song, Hyo Sook | - |
dc.contributor.author | Yoo, Seung Hoon | - |
dc.contributor.author | Yoon, Myonggeun | - |
dc.date.accessioned | 2021-09-03T18:53:24Z | - |
dc.date.available | 2021-09-03T18:53:24Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2016-10-04 | - |
dc.identifier.issn | 1949-2553 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/87207 | - |
dc.description.abstract | Treatment with alternating electric fields at an intermediate frequency (100-300 kHz), referred to as tumor treating fields (TTF) therapy, inhibits cancer cell proliferation. In the present study, we demonstrated that TTF application suppressed the metastatic potential of U87 and U373 glioblastoma cell lines via the NF-kB, MAPK and PI3K/AKT signaling pathways. Wound-healing and transwell assays showed that TTF suppressed cell migration and invasion compared with controls. Soft agar and three-dimensional culture assays showed that TTF inhibited both anchoragedependent (cell proliferation) and anchorage-independent (colony formation) GBM cell growth. TTF dysregulated epithelial-to-mesenchymal transition-related genes, such as vimentin and E-cadherin, which partially accounted for TTF inhibition of cell migration and invasion. We further demonstrated that TTF application suppressed angiogenesis by downregulating VEGF, HIF1a and matrix metalloproteinases 2 and 9. TTF also inhibited NF-kB transcriptional activity. Collectively, our findings show that TTF represents a promising novel anti-invasion and anti-angiogenesis therapeutic strategy for use in GBM patients. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | IMPACT JOURNALS LLC | - |
dc.subject | NF-KAPPA-B | - |
dc.subject | EPITHELIAL-MESENCHYMAL TRANSITIONS | - |
dc.subject | ALTERNATING ELECTRIC-FIELDS | - |
dc.subject | MATRIX METALLOPROTEINASES | - |
dc.subject | MATRIX-METALLOPROTEINASE-9 EXPRESSION | - |
dc.subject | BREAST-CANCER | - |
dc.subject | BRAIN-TUMORS | - |
dc.subject | GLIOMA | - |
dc.subject | METASTASIS | - |
dc.subject | ACTIVATION | - |
dc.title | Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yoon, Myonggeun | - |
dc.identifier.doi | 10.18632/oncotarget.11372 | - |
dc.identifier.scopusid | 2-s2.0-84994158260 | - |
dc.identifier.wosid | 000387281000046 | - |
dc.identifier.bibliographicCitation | ONCOTARGET, v.7, no.40, pp.65125 - 65136 | - |
dc.relation.isPartOf | ONCOTARGET | - |
dc.citation.title | ONCOTARGET | - |
dc.citation.volume | 7 | - |
dc.citation.number | 40 | - |
dc.citation.startPage | 65125 | - |
dc.citation.endPage | 65136 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | NF-KAPPA-B | - |
dc.subject.keywordPlus | EPITHELIAL-MESENCHYMAL TRANSITIONS | - |
dc.subject.keywordPlus | ALTERNATING ELECTRIC-FIELDS | - |
dc.subject.keywordPlus | MATRIX METALLOPROTEINASES | - |
dc.subject.keywordPlus | MATRIX-METALLOPROTEINASE-9 EXPRESSION | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | BRAIN-TUMORS | - |
dc.subject.keywordPlus | GLIOMA | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordAuthor | tumor treating fields | - |
dc.subject.keywordAuthor | glioblastoma multiforme | - |
dc.subject.keywordAuthor | NF-kB | - |
dc.subject.keywordAuthor | metastasis | - |
dc.subject.keywordAuthor | angiogenesis | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.